vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and BXP, Inc. (BXP). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $872.1M, roughly 1.1× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs 0.7%, a 14.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 0.8%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 1.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.
ASTH vs BXP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $950.5M | $872.1M |
| Net Profit | $6.6M | $133.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | 15.3% |
| Revenue YoY | 42.9% | 0.8% |
| Net Profit YoY | 184.4% | 53.0% |
| EPS (diluted) | $0.12 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $872.1M | ||
| Q4 25 | $950.5M | $877.1M | ||
| Q3 25 | $956.0M | $871.5M | ||
| Q2 25 | $654.8M | $868.5M | ||
| Q1 25 | $620.4M | $865.2M | ||
| Q4 24 | $665.2M | $858.6M | ||
| Q3 24 | $478.7M | $859.2M | ||
| Q2 24 | $486.3M | $850.5M |
| Q1 26 | — | $133.0M | ||
| Q4 25 | $6.6M | $248.4M | ||
| Q3 25 | $373.0K | $-121.7M | ||
| Q2 25 | $9.4M | $89.0M | ||
| Q1 25 | $6.7M | $61.2M | ||
| Q4 24 | $-7.8M | $-228.9M | ||
| Q3 24 | $16.1M | $83.6M | ||
| Q2 24 | $19.2M | $79.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 58.8% | ||
| Q3 25 | — | 59.3% | ||
| Q2 25 | — | 59.2% | ||
| Q1 25 | — | 59.2% | ||
| Q4 24 | — | 59.7% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.2% | — |
| Q1 26 | — | 15.3% | ||
| Q4 25 | 0.7% | 28.3% | ||
| Q3 25 | 0.0% | -14.0% | ||
| Q2 25 | 1.4% | 10.2% | ||
| Q1 25 | 1.1% | 7.1% | ||
| Q4 24 | -1.2% | -26.7% | ||
| Q3 24 | 3.4% | 9.7% | ||
| Q2 24 | 3.9% | 9.4% |
| Q1 26 | — | $1.69 | ||
| Q4 25 | $0.12 | $1.56 | ||
| Q3 25 | $0.01 | $-0.77 | ||
| Q2 25 | $0.19 | $0.56 | ||
| Q1 25 | $0.14 | $0.39 | ||
| Q4 24 | $-0.14 | $-1.46 | ||
| Q3 24 | $0.33 | $0.53 | ||
| Q2 24 | $0.40 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $512.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $7.7B |
| Total Assets | $2.2B | $25.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $512.8M | ||
| Q4 25 | $429.5M | $1.5B | ||
| Q3 25 | $463.4M | $861.1M | ||
| Q2 25 | $342.1M | $447.0M | ||
| Q1 25 | $260.9M | $398.1M | ||
| Q4 24 | $290.8M | $1.3B | ||
| Q3 24 | $350.3M | $1.4B | ||
| Q2 24 | $327.7M | $685.4M |
| Q1 26 | — | $7.7B | ||
| Q4 25 | $779.3M | $5.1B | ||
| Q3 25 | $775.5M | $5.0B | ||
| Q2 25 | $765.5M | $5.3B | ||
| Q1 25 | $745.4M | $5.3B | ||
| Q4 24 | $712.7M | $5.4B | ||
| Q3 24 | $704.6M | $5.8B | ||
| Q2 24 | $678.9M | $5.8B |
| Q1 26 | — | $25.1B | ||
| Q4 25 | $2.2B | $26.2B | ||
| Q3 25 | $2.2B | $26.0B | ||
| Q2 25 | $1.4B | $25.6B | ||
| Q1 25 | $1.3B | $25.4B | ||
| Q4 24 | $1.4B | $26.1B | ||
| Q3 24 | $1.3B | $26.4B | ||
| Q2 24 | $1.3B | $25.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 1.5% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $407.8M | ||
| Q3 25 | $10.0M | $274.2M | ||
| Q2 25 | $90.9M | $353.1M | ||
| Q1 25 | $16.6M | $210.0M | ||
| Q4 24 | $-10.9M | $383.7M | ||
| Q3 24 | $34.0M | $286.1M | ||
| Q2 24 | $23.2M | $367.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $362.7M | ||
| Q3 25 | $7.4M | $231.6M | ||
| Q2 25 | $89.5M | $281.5M | ||
| Q1 25 | $13.6M | $152.6M | ||
| Q4 24 | $-13.5M | $312.5M | ||
| Q3 24 | $31.7M | $234.5M | ||
| Q2 24 | $20.4M | $332.4M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 41.4% | ||
| Q3 25 | 0.8% | 26.6% | ||
| Q2 25 | 13.7% | 32.4% | ||
| Q1 25 | 2.2% | 17.6% | ||
| Q4 24 | -2.0% | 36.4% | ||
| Q3 24 | 6.6% | 27.3% | ||
| Q2 24 | 4.2% | 39.1% |
| Q1 26 | — | 1.5% | ||
| Q4 25 | 0.3% | 5.1% | ||
| Q3 25 | 0.3% | 4.9% | ||
| Q2 25 | 0.2% | 8.2% | ||
| Q1 25 | 0.5% | 6.6% | ||
| Q4 24 | 0.4% | 8.3% | ||
| Q3 24 | 0.5% | 6.0% | ||
| Q2 24 | 0.6% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.64× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 3.97× | ||
| Q1 25 | 2.48× | 3.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 3.42× | ||
| Q2 24 | 1.21× | 4.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |